RBC Capital analyst Brian Abrahams maintained a Hold rating on Galapagos (NASDAQ:GLPG) on Friday, setting a price target of $87, which is approximately 15.94% above the present share price of $75.04.
Abrahams expects Galapagos to post earnings per share (EPS) of -$0.88 for the second quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in Galapagos, with an average price target of $101.76.
The analysts price targets range from a high of $133.8 to a low of $87.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $144.46 million and a net profit of -$15.48 million. The company's market cap is $4.92 billion.
According to TipRanks.com, RBC Capital analyst Brian Abrahams is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 5.2% and a 45.68% success rate.
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.